Substance / Medication

Histamine

Overview

Active Ingredient
histamine
RxNorm CUI
5333

Indications

Positive Skin Test Control - Histamine is indicated as an adjunct in allergy skin test for diagnosis, as a positive control to test wheal-flare response of skin for evaluation of skin test response to allergenic extracts.

Labeler: Jubilant HollisterStier LLCUpdated: 2025-11-19T00:00:00.000ZFull label on DailyMed

Boxed Warning

FDA Black Box Warning

This product is to be used by a physician or under the supervision of a physician. For Percutaneous (Scratch, Prick or Puncture) AdministrationHistamine Base: 6mg/mL(Histamine Dihydrochloride: 10mg/mL)

Contraindications

When this intervention should not be used

Positive Skin Test Control - Histamine is contraindicated in patients with a history of hypersensitivity to histamine products, and in patients with hypotension, severe hypertension, vasomotor instability, severe cardiac, pulmonary or renal disease.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

2 trials linked to this intervention

2
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Ventilator-Associated Pneumonia in Patients Using Proton Pump Inhibitors Versus Histamine H2 Receptor Antagonists: A Systematic Review and Meta-Analysis.
Alves Filho Francisco Willamy Pedrosa, Lima Nágila Alves, Mendes Beatriz Ximenes et al. · Respir Care · 2025
PMID: 40474761Meta-Analysis
Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis.
Nishii Yasufumi, Sakuma Kenji, Hamanaka Shun et al. · Neuropsychopharmacol Rep · 2025
PMID: 40567153Meta-AnalysisFull text (PMC)
Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials.
Rayner Daniel G, Liu Ming, Chu Alexandro W L et al. · J Allergy Clin Immunol · 2024
PMID: 38852861Meta-Analysis
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.
Ansotegui Ignacio J, Bousquet Jean, Canonica Giorgio Walter et al. · Curr Med Res Opin · 2024
PMID: 39028636Meta-Analysis
Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
Khasawneh Mais, Black Christopher J, Ford Alexander C · Gastroenterology · 2024
PMID: 38499162Meta-Analysis
Effectiveness and Safety of Histamine H2 Receptor Antagonists: An Umbrella Review of Meta-Analyses.
Meng Rui, Chen Li-Rong, Zhang Man-Li et al. · J Clin Pharmacol · 2023
PMID: 36039014Meta-Analysis
The clinical relationship between histamine-1 receptor antagonists and risk of cancer: a systematic review and meta-analysis.
Bakhtiari Elham, Moazzen Nasrin, Amirabadi Amir et al. · Expert Rev Anticancer Ther · 2023
PMID: 36503360Meta-Analysis
Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon Takhyeon, Kim Yerim, Lee Kyung Joo et al. · Sci Rep · 2023
PMID: 38036592Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Histamine (substance)
SNOMED CT
54235008
UMLS CUI
C0019588
RxNorm CUI
5333
Labeler
Jubilant HollisterStier LLC

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

3
Conditions
1
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.